Search
Pacira Biosciences Inc
PCRXAdd to Watchlist
26.410USD
-0.560-2.08%
Close 07-31 16:00（ET）Quotes delayed by 15 min
1.04BMarket Cap
209.75P/E TTM
Revenue Breakdown
Currency: USDUpdated: Mon, Apr 6
Currency: USDUpdated: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2023
FY2022
FY2021
FY2020
By BusinessUSD
Name
Revenue
Proportion
EXPAREL
575.13M
79.56%
ZILRETTA
116.63M
16.14%
iovera
24.18M
3.34%
Bupivacaine liposome injectable suspension
6.91M
0.96%
Relevant data have not been disclosed by the company yet.
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
EXPAREL
575.13M
79.56%
ZILRETTA
116.63M
16.14%
iovera
24.18M
3.34%
Bupivacaine liposome injectable suspension
6.91M
0.96%